Northern Trust Corp Vaxxinity, Inc. Transaction History

Northern Trust Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.62 - $0.86 $773 - $1,073	-1,248 Reduced 0.37%	333,250 $239,000
Q4 2023 Feb 13, 2024	SELL	$0.7 - $1.31 $12,119 - $22,681	-17,314 Reduced 4.92%	334,498 $284,000
Q3 2023 Nov 13, 2023	BUY	$1.25 - $3.0 $87 - $210	70 Added 0.02%	351,812 $481,000
Q2 2023 Aug 11, 2023	BUY	$1.73 - $2.79 $488,565 - $787,918	282,408 Added 407.32%	351,742 $886,000
Q1 2023 May 15, 2023	BUY	$1.43 - $4.24 $9,296 - $27,564	6,501 Added 10.35%	69,334 $157,000
Q3 2022 Nov 14, 2022	BUY	$1.64 - $2.48 $103,046 - $155,825	62,833 New	62,833 $124,000

198K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.